Partner with NuPotential

NuPotential, Inc. is actively seeking industrial alliance partners and academic collaborators in several areas of mutual benefit.  (add section and list once deals cut, if we have permission)

Cell Reprogramming Biomarkers

As part of its cell reprogramming discovery research, NuPotential has developed several panels of previously unavailable monoclonal antibodies against epigenetic and other markers of cell developmental competence.  Commercial licenses for resale are available on these antibodies.

Novel Assays for Assessing State of Cell Development

NuPotential scientists have developed or filed disclosures on several new assays relevant to cell therapy research.  NuPotential welcomes inquiries about these assays for potential commercialization.

Compounds designed to direct or influence cell reprogramming and differentiation.
New therapeutic technologies reliant upon cell reprogramming.
New technologies for gene targeting.
New assays/microarrays or other multiplexed methods for assessing expression of key
protein biomarkers relevant to cell reprogramming and differentiation.